Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
Cerilliant
UBS
Fish and Richardson
US Department of Justice
Chinese Patent Office
Deloitte
Cantor Fitzgerald
Federal Trade Commission

Generated: January 18, 2018

DrugPatentWatch Database Preview

Cimetidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for cimetidine and what is the scope of cimetidine patent protection?

Cimetidine
is the generic ingredient in seven branded drugs marketed by Glaxosmithkline, Apotex, Chartwell Molecules, Contract Pharmacal, Cycle Pharms Ltd, Dava Pharms Inc, Ivax Sub Teva Pharms, L Perrigo Co, Mylan, Perrigo, Pliva, Sandoz, Sandoz Inc, Teva, Upsher-smith Labs, Watson Labs Inc, Watson Labs Teva, Medtech Products, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Ani Pharms Inc, Apotex Inc, G And W Labs Inc, Hi Tech Pharma, Pharm Assoc, and Wockhardt, and is included in fifty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for cimetidine. Twenty-seven suppliers are listed for this compound.
Pharmacology for cimetidine
Medical Subject Heading (MeSH) Categories for cimetidine

US Patents and Regulatory Information for cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074296-001 Mar 28, 1997 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo CIMETIDINE cimetidine TABLET;ORAL 074972-001 Jun 19, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Sub Teva Pharms CIMETIDINE cimetidine TABLET;ORAL 074402-001 May 30, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074345-001 Jan 31, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dava Pharms Inc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride INJECTABLE;INJECTION 074428-001 Apr 25, 1996 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CIMETIDINE cimetidine TABLET;ORAL 075122-001 Jun 19, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc CIMETIDINE HYDROCHLORIDE cimetidine hydrochloride SOLUTION;ORAL 074610-001 Sep 26, 1996 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CIMETIDINE cimetidine TABLET;ORAL 074250-001 Jun 29, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva CIMETIDINE cimetidine TABLET;ORAL 074151-002 May 17, 1994 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz Inc CIMETIDINE cimetidine TABLET;ORAL 074250-002 Jun 29, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for cimetidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-004 Dec 14, 1983 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-005 Apr 30, 1986 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-004 Dec 14, 1983 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Glaxosmithkline TAGAMET cimetidine TABLET;ORAL 017920-005 Apr 30, 1986 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Baxter
McKinsey
Johnson and Johnson
Argus Health
Daiichi Sankyo
Medtronic
Teva
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot